Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis

被引：148
|
作者：
Alangaden, GJ
Kreiswirth, BN
Aouad, A
Khetarpal, M
Igno, FR
Moghazeh, SL
Manavathu, EK
Lerner, SA
机构：
[1] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA
[3] Publ Hlth Res Inst City New York Inc, TB Ctr, New York, NY 10016 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 05期
关键词：
D O I：
10.1128/AAC.42.5.1295
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
An A1400G mutation of the ns gene was identified in Mycobacterium tuberculosis (MTB) strain ATCC 35827 and in 13 MTB clinical isolates resistant to amikacin-kanamycin (MICs, >128 mu g/ml). High-level cross-resistance may result from such a mutation since MTB has a single copy of the rrs gene. Another mechanism(s) may account for high-level amikacin-kanamycin resistance in two mutants and lower levels of resistance in four clinical isolates, all lacking the A1400G mutation.
引用
收藏
页码：1295 / 1297
页数：3
相关论文
共 50 条
  • [1] Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis
    Krüüner, A
    Jureen, P
    Levina, K
    Ghebremichael, S
    Hoffner, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2971 - 2973
  • [2] Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex
    Vargas, Roger, Jr.
    Freschi, Luca
    Spitaleri, Andrea
    Tahseen, Sabira
    Barilar, Ivan
    Niemann, Stefan
    Miotto, Paolo
    Cirillo, Daniela Maria
    Koser, Claudio U.
    Farhat, Maha R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (11)
  • [3] Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin
    Sugawara, I.
    Zhang, J.
    Lie, C.
    [J]. INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2009, 47 (06) : 520 - 522
  • [4] BIOCHEMICAL MECHANISM OF KANAMYCIN RESISTANCE IN MYCOBACTERIUM-TUBERCULOSIS
    MITSUHASHI, S
    TANAKA, T
    KAWABE, H
    UMEZAWA, H
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1977, 21 (06) : 325 - 327
  • [5] In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin
    Dijkstra, J. A.
    van der Laan, T.
    Akkerman, O. W.
    Bolhuis, M. S.
    de lange, W. C. M.
    Kosterink, J. G. W.
    van der Werf, T. S.
    Alffenaar, J. W. C.
    van Soolingen, D.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [6] Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin
    Kumar, Bhavnesh
    Sharma, Divakar
    Sharma, Prashant
    Katoch, Vishwa Mohan
    Venkatesan, Krishnamurthy
    Bisht, Deepa
    [J]. JOURNAL OF PROTEOMICS, 2013, 94 : 68 - 77
  • [7] Correlation between phenotypic and genotypic drug resistance to kanamycin and amikacin in clinical isolates of Mycobacterium tuberculosis
    Ahmadi, Azam
    Sadrnia, Maryam
    Arjomandzadegan, Mohammad
    Titov, Leonid
    [J]. IRANIAN JOURNAL OF MICROBIOLOGY, 2020, 12 (05) : 503 - 504
  • [8] Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review
    Georghiou, Sophia B.
    Magana, Marisa
    Garfein, Richard S.
    Catanzaro, Donald G.
    Catanzaro, Antonino
    Rodwell, Timothy C.
    [J]. PLOS ONE, 2012, 7 (03):
  • [9] STUDIES ON THE KANAMYCIN-RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS .1. GENERAL FEATURE OF KANAMYCIN-RESISTANCE SYSTEM
    TSUKAMURA, M
    NODA, Y
    HAYASHI, M
    TORII, F
    [J]. JOURNAL OF ANTIBIOTICS, 1960, 13 (01): : 70 - 73
  • [10] Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis
    Willby, Melisa J.
    Green, Keith D.
    Gajadeera, Chathurada S.
    Hou, Caixia
    Tsodikov, Oleg V.
    Posey, James E.
    Garneau-Tsodikova, Sylvie
    [J]. ACS CHEMICAL BIOLOGY, 2016, 11 (06) : 1639 - 1646
12345